Oracle launches AI-driven patient portal
First announced last fall, the portal leverages foundation models from OpenAI to help patients navigate their medical records. Users can use the patient portal to review their medical records, engage with providers, schedule appointments, and ask questions to receive AI-generated explanations of diagnoses, lab results…
First announced last fall, the portal leverages foundation models from OpenAI to help patients navigate their medical records. Users can use the patient portal to review their medical records, engage with providers, schedule appointments, and ask questions to receive AI-generated explanations of diagnoses, lab.
The portal has guardrails that prevent the AI from dispensing medical advice or providing diagnoses or treatment recommendations, and it highlights all AI-generated text to differentiate it from provider notes, Oracle says. With it, clinicians can use voice commands to access patient information like.
What Happened
It’s currently only available to ambulatory providers in the U.S., though Oracle said it plans to launch the new EHR for the acute care market this year. The patient portal launch represents Oracle's continued effort to differentiate itself in the competitive EHR.
In August 2025, the company launched an AI-backed EHR.
As of 2024, its competitor Epic controlled nearly double Oracle's market share in the acute care EHR space.
The agency said it would increase the number of MA plan audits and complete its backlog of reviews by investing in technology and growing its medical coding workforce.
Key Details
The FDA said it’s sending letters to drugmakers demanding they take down or modify ads that don't comply with federal guidelines, out of concern consumers aren’t seeing a “fair balance” of risks and benefits in drug ads.
The agency said it would increase the number of MA plan audits and complete its backlog of reviews by investing in technology and growing its medical coding workforce.
The FDA said it’s sending letters to drugmakers demanding they take down or modify ads that don't comply with federal guidelines, out of concern consumers aren’t seeing a “fair balance” of risks and benefits.
What Reports Say
Coverage of the story so far points to:
Continued reporting by Healthcare Dive as more details emerge